Pharmaceutical soft gelatin capsule dosage form with modified guar gum

1. A pharmaceutical soft gelatin capsule dosage form comprising:

a shell comprising gelatin and a plasticizer; and

a fill encapsulated by the shell, the fill containing less than 1.0% w/w water prior to encapsulation and further comprising at least one pharmaceutically active ingredient, one or more polyethylene glycol, and hydroxypropyl guar gum;

wherein the pharmaceutical soft gelatin capsule dosage form is for vaginal administration; and

wherein the fill after encapsulation comprises about 6.0 to 11.0% w/w water.

2. The pharmaceutical soft gelatin capsule dosage form of claim 1 , wherein the at least one active ingredient is selected from the group consisting of steroids and low dose non-steroidal compounds, their pharmaceutically acceptable salts, esters, hydrates, prodrugs and derivatives.

3. The pharmaceutical soft gelatin capsule dosage form of claim 2 , wherein the at least one active ingredient is selected from the group consisting of estradiol, ethinyl estradiol, norethindrone acetate, etonogestrel, darifenacin, udenafil, risedronate, alendronate, etidronate, ibandronate, clodronate, and zoledronate.

4. The pharmaceutical soft gelatin capsule dosage form of claim 2 , wherein the at least one active ingredient is selected from the group consisting of estradiol, its salts, esters, hydrates, prodrugs and its derivatives.

5. The pharmaceutical soft gelatin capsule dosage form of claim 4 , wherein the amount of the hydroxypropyl guar gum is about 0.5% to about 3.0% by weight of the total weight of the fill.

6. The pharmaceutical soft gelatin capsule dosage form of claim 1 , wherein the polyethylene glycol has a molecular weight of less than 900.

7. The pharmaceutical soft gelatin capsule dosage form of claim 6 , wherein the fill further comprises at least one additional polyethylene glycol with a molecular weight of greater than 900.

8. The pharmaceutical soft gelatin capsule dosage form of claim 7 , wherein the polyethylene glycol is a combination of PEG 400 and PEG 3350.

9. The pharmaceutical soft gelatin capsule dosage form of claim 8 , wherein the PEG 400 and PEG 3350 are present in weight ratio of between 90:10 and 95:5.

10. The pharmaceutical soft gelatin capsule dosage form of claim 1 , wherein the fill further comprises an antioxidant.

11. The pharmaceutical soft gelatin capsule dosage form of claim 10 , wherein the antioxidant is tocopherol.

12. The pharmaceutical soft gelatin capsule dosage form of claim 1 , wherein the fill further comprises a solvent.

13. The pharmaceutical soft gelatin capsule dosage form of claim 12 , wherein the solvent is propylene glycol.

14. The pharmaceutical soft gelatin capsule dosage form of claim 13 , wherein the propylene glycol is present in an amount of about 5% by weight of the total weight of the fill.

15. The pharmaceutical soft gelatin capsule dosage form of claim 5 , wherein the amount of the hydroxypropyl guar gum is about 1.5% by weight of the total weight of the fill.

16. The pharmaceutical soft gelatin capsule dosage form of claim 1 , wherein the amount of the hydroxypropyl guar gum is about 0.5% to about 3.0% by weight of the total weight of the fill.

17. A pharmaceutical soft gelatin capsule dosage form comprising:

a shell comprising gelatin and a plasticizer; and

a fill encapsulated by the shell, the fill containing less than 1.0% w/w water prior to encapsulation and further comprising at least one pharmaceutically active ingredient, one or more polyethylene glycol, and hydroxypropyl guar gum;

wherein the pharmaceutical soft gelatin capsule dosage form is for vaginal administration; and

wherein the pharmaceutical soft gelatin capsule dosage form maintains hardness for at least 15 months when stored at 25° C. and a relative humidity of 60%.